David James Lennon is CHIEF EXECUTIVE OFFICER of Aadi Bioscience, Inc.. Currently has a direct ownership of 33,429 shares of AADI, which is worth approximately $63,849. The most recent transaction as insider was on Mar 03, 2025, when has been sold 5,690 shares (Common Stock) at a price of $2.35 per share, resulting in proceeds of $13,371. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.4K
46.18% 3M change
n/a 12M change
Total Value Held $63,849

David James Lennon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 03 2025
SELL
Open market or private sale
$13,371 $2.35 p/Share
5,690 Reduced 14.55%
33,429 Common Stock
Mar 01 2025
BUY
Exercise of conversion of derivative security
-
16,250 Added 29.35%
39,119 Common Stock
Oct 03 2024
SELL
Open market or private sale
$18,796 $1.94 p/Share
9,689 Reduced 29.76%
22,869 Common Stock
Oct 02 2024
BUY
Exercise of conversion of derivative security
-
32,558 Added 50.0%
32,558 Common Stock
DJL

David James Lennon

CHIEF EXECUTIVE OFFICER
Pacific Palisades, CA

Track Institutional and Insider Activities on AADI

Follow Aadi Bioscience, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AADI shares.

Notify only if

Insider Trading

Get notified when an Aadi Bioscience, Inc. insider buys or sells AADI shares.

Notify only if

News

Receive news related to Aadi Bioscience, Inc.

Track Activities on AADI